The journey from raw chemical components to life-saving pharmaceuticals is complex, requiring precision, expertise, and unwavering quality control. For manufacturers producing Montelukast, a crucial medication for asthma and allergy management, the procurement of the correct intermediates is a critical first step. (S)-1-(3-(2-(7-Chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propan-1-ol, identified by its CAS number 142569-70-8, stands out as a key building block in this synthesis.

Understanding the chemical properties of this compound is essential for anyone involved in pharmaceutical R&D or manufacturing. Its designation as a pharmaceutical raw material highlights its direct role in the creation of active pharmaceutical ingredients (APIs). The purity level, typically stated as 97% minimum, is a testament to the advanced chemical synthesis processes employed to produce it. NINGBO INNO PHARMCHEM CO., LTD., operating as a prominent supplier in China, ensures that these standards are met consistently.

For pharmaceutical companies aiming to secure a stable supply chain for their Montelukast production, sourcing from a reputable manufacturer is paramount. When you choose to buy CAS 142569-70-8 from us, you are partnering with a company dedicated to excellence in chemical synthesis. Our goal is to facilitate the efficient and reliable production of medications that address significant health concerns. We understand that the price and availability of such critical intermediates can impact project timelines and costs, and we strive to offer competitive solutions.

The broader landscape of pharmaceutical intermediates is vast, but compounds like (S)-1-(3-(2-(7-Chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propan-1-ol are foundational for specific therapeutic areas. By focusing on the needs of the pharmaceutical industry, NINGBO INNO PHARMCHEM CO., LTD. provides not just chemicals, but solutions that contribute to better healthcare outcomes globally. We invite inquiries from potential partners seeking quality pharmaceutical raw materials and expert chemical synthesis support.